Clinical Trial Update: Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 pivotal trial evaluating the efficacy, safety and tolerability of dupilumab in adults with moderate-to-severe c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-03-17